CASE REPORT
Published on 04 Feb 2025
Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report
doi 10.3389/fonc.2025.1487334
- 105 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Drug Discovery in Cancer Research: Success Stories and Open Challenges
Drug Discovery in Cancer Research: Success Stories and Open Challenges
10k
Total downloads
32k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 03 Feb 2025
Discovery of highly potent and novel LSD inhibitors for the treatment of acute myeloid leukemia: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
doi 10.3389/fphar.2025.1510319
ORIGINAL RESEARCH
Accepted on 27 Jan 2025
Adverse Drug Reactions to Atezolizumab in Combination with Bevacizumab in Hepatocellular Carcinoma Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
doi 10.3389/fphar.2025.1448095
SYSTEMATIC REVIEW
Published on 08 Jan 2025
Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models
doi 10.3389/fonc.2024.1487376
- 337 views
ORIGINAL RESEARCH
Published on 03 Jan 2025
Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties
doi 10.3389/fphar.2024.1511627
- 504 views
ORIGINAL RESEARCH
Published on 12 Nov 2024
Efficacy and safety of regorafenib for the treatment of metastatic colorectal cancer in routine clinical practice: results from a Spanish hospital
doi 10.3389/fonc.2024.1446945
- 436 views
REVIEW
Published on 05 Nov 2024
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
doi 10.3389/fphar.2024.1475998
- 1,126 views
CASE REPORT
Published on 01 Nov 2024
Case report: Treatment with ensartinib shows good response to SQSTM1-ALK fusion in lung adenocarcinoma
doi 10.3389/fphar.2024.1433894
- 528 views
CASE REPORT
Published on 26 Sep 2024
A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma
doi 10.3389/fphar.2024.1447582
- 573 views
REVIEW
Published on 27 Aug 2024
Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis
doi 10.3389/fphar.2024.1446486
- 875 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Aug 2024
CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017–2023)
doi 10.3389/fphar.2024.1434231
- 1,158 views
CASE REPORT
Published on 13 Aug 2024
Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments
doi 10.3389/fphar.2024.1431542
- 593 views
- 1 citation
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Experimental Pharmacology and Drug Discovery
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 32kTopic views
- 20kArticle views
- 10kArticle downloads